<DOC>
	<DOCNO>NCT00381537</DOCNO>
	<brief_summary>Randomised control trial use phenobarbitone carbamazepine childhood epilepsy Bangladesh particular reference behavioural side effect .</brief_summary>
	<brief_title>Prediction Childhood Epilepsy Outcome Bangladesh</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>Active epilepsy Aged 215 year Excluded absence Myoclonic malignant epilepsy syndromes Major motor cognitive impairment Those currently receive antiepilepsy drug .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>childhood epilepsy</keyword>
	<keyword>Active childhood epilepsy</keyword>
</DOC>